Literature DB >> 23318175

D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation.

Brian F O'Dowd1, Tuan Nguyen, Xiaodong Ji, Susan R George.   

Abstract

We have demonstrated that D(5) and D(2) dopamine receptors exist as heteromers in cells, and determined these receptor interact through amino acids in the cytoplasmic regions of each receptor. Specifically involved in heteromer formation we identified in the carboxyl tail of the D(5) receptor three adjacent glutamic acid residues, and in intracellular loop 3 of the D(2) receptor two adjacent arginine residues. Any pairing of these three D(5) receptor glutamic acids were sufficient for heteromer formation. These identified residues in D(5) and D(2) receptors are oppositely charged and likely interact by electrostatic interactions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318175      PMCID: PMC3744868          DOI: 10.1016/j.bbrc.2012.12.139

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  G-protein-coupled receptor oligomerization and its potential for drug discovery.

Authors:  Susan R George; Brian F O'Dowd; Samuel P Lee
Journal:  Nat Rev Drug Discov       Date:  2002-10       Impact factor: 84.694

2.  Dopamine receptor oligomerization visualized in living cells.

Authors:  Brian F O'Dowd; Xiaodong Ji; Mohammad Alijaniaram; Ryan D Rajaram; Michael M C Kong; Asim Rashid; Tuan Nguyen; Susan R George
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

3.  Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors.

Authors:  Brian F O'Dowd; Mohammad Alijaniaram; Xiaodong Ji; Tuan Nguyen; Richard M Eglen; Susan R George
Journal:  J Biomol Screen       Date:  2007-02-08

Review 4.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

5.  Disruption of the mu-delta opioid receptor heteromer.

Authors:  Brian F O'Dowd; Xiaodong Ji; Paul B O'Dowd; Tuan Nguyen; Susan R George
Journal:  Biochem Biophys Res Commun       Date:  2012-05-11       Impact factor: 3.575

6.  Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation.

Authors:  Brian F O'Dowd; Xiaodong Ji; Tuan Nguyen; Susan R George
Journal:  Biochem Biophys Res Commun       Date:  2011-11-12       Impact factor: 3.575

7.  The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.

Authors:  Melissa L Perreault; Ahmed Hasbi; Mohammed Alijaniaram; Theresa Fan; George Varghese; Paul J Fletcher; Philip Seeman; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2010-09-23       Impact factor: 5.157

8.  Separation and reformation of cell surface dopamine receptor oligomers visualized in cells.

Authors:  Brian F O'Dowd; Xiaodong Ji; Mohammad Alijaniaram; Tuan Nguyen; Susan R George
Journal:  Eur J Pharmacol       Date:  2011-03-01       Impact factor: 4.432

9.  G protein-coupled receptor oligomerization for what?

Authors:  Francisco Ciruela; Antoni Vallano; Josep M Arnau; Silvia Sánchez; Dasiel O Borroto-Escuela; Luigi F Agnati; Kjell Fuxe; Víctor Fernández-Dueñas
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

10.  Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.

Authors:  Christopher H So; Vaneeta Verma; Mohammad Alijaniaram; Regina Cheng; Asim J Rashid; Brian F O'Dowd; Susan R George
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

View more
  8 in total

Review 1.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

2.  The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes.

Authors:  Alexander O Tarakanov; Kjell Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2015-07-02       Impact factor: 3.575

3.  Intranasal delivery of a peptide with antidepressant-like effect.

Authors:  Virginia Brown; Fang Liu
Journal:  Neuropsychopharmacology       Date:  2014-03-17       Impact factor: 7.853

4.  A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.

Authors:  Ahmed Hasbi; Melissa L Perreault; Maurice Y F Shen; Lucia Zhang; Ryan To; Theresa Fan; Tuan Nguyen; Xiaodong Ji; Brian F O'Dowd; Susan R George
Journal:  FASEB J       Date:  2014-07-25       Impact factor: 5.191

Review 5.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

Review 6.  Computational approaches for modeling GPCR dimerization.

Authors:  Xuan-Yu Meng; Mihaly Mezei; Meng Cui
Journal:  Curr Pharm Biotechnol       Date:  2014       Impact factor: 2.837

7.  Transcriptional signatures in prefrontal cortex confer vulnerability versus resilience to food and cocaine addiction-like behavior.

Authors:  Mohit Navandar; Elena Martín-García; Rafael Maldonado; Beat Lutz; Susanne Gerber; Inigo Ruiz de Azua
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

8.  The Conserved Arginine Cluster in the Insert of the Third Cytoplasmic Loop of the Long Form of the D₂ Dopamine Receptor (D2L-R) Acts as an Intracellular Retention Signal.

Authors:  Valentina Kubale; Kaja Blagotinšek; Jane Nøhr; Karin A Eidne; Milka Vrecl
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.